3M Q3FY26 Results: Adj. EPS $2.50 beats estimate, sales miss
- Adjusted EPS of $2.50 beat consensus estimate of $2.39 by 4.6%
- Quarterly sales of $6.60 billion missed consensus estimate of $6.608 billion
- Revenue increased 4.76% YoY from $6.30 billion in Q3FY25
- EPS grew 14.16% YoY compared to $2.19 in the same period last year

*this image is generated using AI for illustrative purposes only.
3M Company reported third-quarter adjusted earnings of $2.50 per share, beating the analyst consensus estimate of $2.39 by 4.6%. This marks a 14.16% increase from $2.19 per share in the year-ago period.
Quarterly sales clocked in at $6.60 billion, missing the consensus estimate of $6.608 billion by 0.12%. This represents a 4.76% increase over the $6.30 billion reported in the corresponding quarter last year. The results follow a strong second-quarter performance reported on July 21, where the company exceeded expectations and raised its full-year adjusted EPS guidance.
Turnaround Measures and Cash Return
The upcoming results provide further hints on the turnaround led by CEO Bill Brown. In the second quarter, revenue rose 5.4%, with operating margin rising by 40 bps to 24.9%. Management continued returning cash to investors, distributing $1.4 billion through buybacks and dividends. The board remains on track to hit $10 billion in returns through 2027.
Innovation remains a key driver, with 92 new products launched recently and a plan to launch 350 new products this year. Additionally, the company is restructuring its customer service division, shifting most operations to the Philippines, a move that will impact about 600 employees.
Analyst Price Target Revisions
In the weeks leading up to the earnings call, several high-accuracy analysts have adjusted their ratings and price targets for the stock. The following table summarizes recent changes by key market participants:
| Analyst Firm | Analyst Name | Rating | Price Target Change | Date | Accuracy Rate |
|---|---|---|---|---|---|
| JP Morgan | Chigusa Katoku | Overweight | Cut to $185 (from $205) | October 9, 2026 | 53% |
| Wells Fargo | Stephen Tusa | Equal-Weight | Initiated at $195 | September 25, 2026 | 71% |
| Mizuho | Brett Linzey | Neutral | Raised to $180 (from $160) | July 23, 2026 | 71% |
| UBS | Amit Mehrotra | Buy | Raised to $218 (from $190) | July 22, 2026 | 76% |
| Citigroup | Andrew Kaplowitz | Neutral | Raised to $183 (from $166) | July 22, 2026 | 80% |
What the Numbers Show
The divergence in analyst sentiment is notable. While UBS maintains a Buy rating with the highest price target of $218, JP Morgan cut its target to $185 despite maintaining an Overweight stance. Meanwhile, Mizuho and Citigroup, both holding Neutral ratings, raised their targets to $180 and $183 respectively. This suggests that while some firms remain cautious on the upside potential, others see continued value, with the consensus price targets clustering between $180 and $195.
A key risk noted is valuation; the forward price-to-earnings ratio of 18.4 is higher than the five-year average of 15.5, despite single-digit revenue growth expectations. The latest results highlight a mixed picture: profitability outperformed expectations significantly, while top-line growth lagged slightly behind forecasts.
Market Reaction and Technicals
3M shares gained 0.6% to trade at $163.79 on Wednesday. However, the stock remains in a correction after falling 10% from its high for the year. The daily chart shows a downward trend from $184 in August to a low of $160 earlier this month, which coincided with the 50% Fibonacci Retracement level.
The stock has settled above the 200-day Exponential Moving Average (EMA) and formed a double-bottom pattern, often viewed as a bullish reversal sign. Key resistance lies at $170, the highest point in September, while support is established at $160.
How might the restructuring of customer service operations to the Philippines impact 3M's long-term operating margins and employee retention rates?
Will the significant gap between strong EPS growth and slightly missed revenue targets influence investor sentiment regarding 3M's valuation premium relative to its historical averages?
Can 3M sustain its $10 billion cash return plan through 2027 if top-line growth remains in the single digits amid potential macroeconomic headwinds?

































